March 29, 2022 12:22 PM EDT
Pharma
Marketing

Mar­ket­ingRx roundup: No­vo Nordisk Type 1 cy­cling team stars in doc­u­men­tary; GSK, Vi­a­tris, Vi­iV top in­no­va­tion list

Beth Snyder Bulik

Senior Editor

Team No­vo Nordisk’s 17 pro­fes­sion­al cy­clists are all liv­ing with Type 1 di­a­betes and prov­ing with every race what’s pos­si­ble. And now the world is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times